Corpus Intelligence IC Memo — REHABILITATION HOSPITAL OF INDIANA 2026-04-26 16:36 UTC
IC Memo — REHABILITATION HOSPITAL OF INDIANA
Investment Committee Memorandum | IN | 91 beds | Grade D | EBITDA uplift $3.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

REHABILITATION HOSPITAL OF INDIANA

CCN 153028 | MARION, IN | 91 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

REHABILITATION HOSPITAL OF INDIANA is a 91-bed suburban community hospital in MARION, IN with $43.2M in net patient revenue and a -7.1% operating margin. The hospital serves a payer mix of 29.5% Medicare, 2.9% Medicaid, and 67.7% commercial.

Thesis: Turnaround. Our ML models identify $3.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.1% to 0.3% (+736bps).

Net Revenue HCRIS$43.2M
Current EBITDA COMPUTED$-3.0M
Operating Margin COMPUTED-7.1%
Occupancy HCRIS56.4%
Revenue / Bed COMPUTED$474K
Net-to-Gross HCRIS36.7%
Distress Probability ML48.2%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
62
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of -7.1% places it below the state median. Among 62 size-comparable peers (46-182 beds), the median margin is 4.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (46-182), prioritizing same-state peers. 62 hospitals in the comp set.

HospitalStateBedsRevenueMargin
REHABILITATION HOSPITAL OF IND (Target)IN91$43.2M-7.1%
HENDRICKS REGIONAL HEALTHIN130$423.4M-3.6%
IU HEALTH NORTH HOSPITALIN153$413.3M24.2%
FRANCISCAN HEALTH LAFAYETTEIN177$377.7M2.7%
ST. MARY MEDICAL CENTER INC.IN180$319.2M9.5%
COMMUNITY HOSPITAL SOUTHIN169$315.7M14.4%
IU HEALTH WEST HOSPITALIN174$288.7M9.0%
FRANCISCAN HEALTH MICHIGAN CITIN119$276.7M6.1%
ASCENSION ST. VINCENT CARMELIN124$268.5M38.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$906K+210bp18mo
Cost to Collect4.5%2.5%$863K+200bp12mo
Denial Rate Reduction12.0%6.5%$854K+198bp12mo
A/R Days Reduction5200.0%3800.0%$525K+122bp9mo
Clean Claim Rate88.0%96.0%$28K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$906K
Cost to Collect
$863K
Denial Rate Reduction
$854K
A/R Days Reduction
$525K
Clean Claim Rate
$28K
Total EBITDA Uplift$3.2M
Current EBITDA$-3.0M
+ RCM Uplift+$3.2M
Pro Forma EBITDA$132K
Current Margin-7.1%
Pro Forma Margin0.3%
WC Released (1x)$1.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.7M$11.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.7M$11.3M0.00x-100.0%
Bull Case9.0x11.0x$-4.2M$20.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.2M$20.9M0.00x-100.0%
Bear Case11.0x10.0x$-5.2M$-2.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-5.2M$-4.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 62 hospitals with 46-182 beds
  • Same-state prioritization (n=63)
  • Comp margins: P25=-11.2% / P50=4.3% / P75=14.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.